HighVista Strategies’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-110,079
| Closed | -$5.23M | – | 147 |
|
|
2025
Q3 | $5.23M | Buy |
110,079
+50,086
| +83% | +$2.43M | 1.28% | 19 |
|
|
2025
Q2 | $3.2M | Buy |
59,993
+35,926
| +149% | +$1.63M | 1.18% | 13 |
|
|
2025
Q1 | $974K | Buy |
24,067
+11,538
| +92% | +$489K | 0.38% | 113 |
|
|
2024
Q4 | $349K | Buy |
+12,529
| New | +$379K | 0.13% | 134 |
|
|
2023
Q4 | – | Sell |
-11,408
| Closed | -$577K | – | 128 |
|
|
2023
Q3 | $577K | Buy |
+11,408
| New | +$531K | 0.27% | 90 |
|
|
2023
Q2 | – | Sell |
-18,629
| Closed | -$713K | – | 136 |
|
|
2023
Q1 | $713K | Hold |
18,629
| – | – | 0.58% | 59 |
|
|
2022
Q4 | $1.02M | Buy |
+18,629
| New | +$798K | 0.61% | 42 |
|
|
2021
Q1 | – | Sell |
-27,739
| Closed | -$716K | – | 127 |
|
|
2020
Q4 | $716K | Buy |
+27,739
| New | +$772K | 0.46% | 53 |
|
